Journey Medical Corporation (DERM)
NASDAQ: DERM · Real-Time Price · USD
5.11
-0.01 (-0.18%)
May 5, 2026, 10:50 AM EDT - Market open
Journey Medical Employees
Journey Medical had 58 employees as of December 31, 2025. The number of employees increased by 17 or 41.46% compared to the previous year.
Employees
58
Change (1Y)
17
Growth (1Y)
41.46%
Revenue / Employee
$1,066,517
Profits / Employee
-$197,086
Market Cap
139.68M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 58 | 17 | 41.46% |
| Dec 31, 2024 | 41 | 0 | - |
| Dec 31, 2023 | 41 | 21 | 105.00% |
| Dec 31, 2022 | 20 | -70 | -77.78% |
| Dec 31, 2021 | 90 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Organigram Global | 1,137 |
| Aurora Cannabis | 1,073 |
| Lifecore Biomedical | 382 |
| Anika Therapeutics | 235 |
| Alpha Teknova | 158 |
| Cumberland Pharmaceuticals | 93 |
| Assertio Holdings | 53 |
| Cardiol Therapeutics | 18 |
DERM News
- 14 days ago - Journey Medical Corporation Secures Contract with Third Major GPO for Emrosi™ - GlobeNewsWire
- 4 weeks ago - Journey Medical Corporation Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses - GlobeNewsWire
- 5 weeks ago - Journey Medical Earnings Call Transcript: Q4 2025 - Transcripts
- 5 weeks ago - Journey Medical Corporation Reports Full-Year 2025 Financial Results and Recent Corporate Highlights - GlobeNewsWire
- 6 weeks ago - Journey Medical Corporation to Announce Year End 2025 Financial Results on March 25, 2026 - GlobeNewsWire
- 5 months ago - Journey Medical Corporation Announces Publication of Clinical Trial Results Assessing the Impact of Emrosi™ (DFD-29) on Microbial Flora of Healthy Adults in the Journal of Drugs in Dermatology - GlobeNewsWire
- 6 months ago - Journey Medical Earnings Call Transcript: Q3 2025 - Transcripts
- 6 months ago - Journey Medical Corporation Reports Third Quarter 2025 Financial Results and Recent Corporate Highlights - GlobeNewsWire